BioCryst Pharmaceuticals (BCRX)
Commercializes oral ORLADEYO and develops injectable navenibart for hereditary angioedema.
$8.76
vs last close−0.00 (−0.01%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 103.55% | 264.60M shares | |
|---|---|---|---|
| 335 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 6.96% | 17.78M shares | |
| 18 holders · as of Sep 2, 2026 | |||
| Adds to | 110.51% | ||
255.54M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 110.51%; nothing is left for Other.
13F, as of Jun 30, 2026
335 holders · 264.60M shares · 57 new positions · 189 increased · 89 reduced · 39 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 23.89M | 9.35% | +1.24M | Aug 7, 2026 |
| Ra Capital Management, L.P. | 15.83M | 6.19% | 0 | Aug 14, 2026 |
| State Street Corp | 15.19M | 5.94% | +2.98M | Aug 7, 2026 |
| Deerfield Management Company, L.P. (Series C) | 15.10M | 5.91% | +58.4K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 11.36M | 4.45% | +228.5K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 11.14M | 4.36% | −105.5K | Aug 13, 2026 |
| TCG Crossover Management, LLC | 11.02M | 4.31% | 0 | Aug 14, 2026 |
| Perceptive Advisors LLC | 10.31M | 4.03% | +2.87M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 8.40% | 17.48M | 13G | Apr 17, 2025 |
| RA Capital Management, L.P. | 7.30% | 15.30M | 13G | Nov 12, 2025 |
| Deerfield Mgmt, L.P. | 6.81% | 14.34M | 13G | Feb 12, 2026 |
| State Street Corporation | 6.00% | 15.19M | 13G | Aug 7, 2026 |
| Vanguard Capital Management | 5.16% | 12.96M | 13G | Apr 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 18, 2026 | Amy E. McKeedirector | Sale | 11,180 | $8.97 | 31,252 |
| May 13, 2026 | Alane P. Barnesofficer: Chief Legal Officer | Sale | 62,500 | $9.54 | 400,703 |
| Mar 20, 2026 | Theresa Heggiedirector | Sale | 49,933 | $10.11 | 65,352 |
| Mar 16, 2026 | Alane P. Barnesofficer: Chief Legal Officer | Sale | 150,000 | $9.15 | 400,703 |
| Dec 22, 2025 | Alane P. Barnesofficer: Chief Legal Officer | Sale | 21,773 | $7.65 | 398,751 |
| Dec 15, 2025 | Alane P. Barnesofficer: Chief Legal Officer | Sale | 21,210 | $7.65 | 315,726 |
| Dec 3, 2025 | Alane P. Barnesofficer: Chief Legal Officer | Sale | 19,770 | $7.65 | 345,476 |
| Dec 2, 2025 | Alane P. Barnesofficer: Chief Legal Officer | Sale | 50,906 | $7.21 | 365,246 |
| Dec 1, 2025 | Alane P. Barnesofficer: Chief Legal Officer | Sale | 91,004 | $7.10 | 416,152 |
| Nov 13, 2025 | Machelle Sandersdirector | Sale | 9,600 | $7.14 | 30,642 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jul 10, 2026 | Sep 7, 2026 | |
| Rep. Gilbert Ray Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jul 10, 2026 | Sep 7, 2026 | |
| Rep. Gilbert Ray Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jul 9, 2026 | Sep 7, 2026 |